Botanical Innovations Products Contain Concentrated Secondary Phenolic Compounds.
Secondary Phenolic compounds have a number of Pharmacological Actions which add to the functionality of Botanical Innovations products.
|Plant Extracts||Ferment Plant Extracts||Ferment Fruit & Vinegars||Cold Pressed Oils||Fruit Powders||Essential Oils|
Pharmacological Actions the Secondary Phenolic Compounds in Botanical Innovations Products
Table Secondary Phenolic Compounds Pharmacological Actions
Pharmacological Action Definitions
Antioxidants inhibit or retard oxidation reactions. May counteract the damaging effects of oxidation in animal tissues.
May prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Agents that may assist in the prevention of blood clotting.
Free Radical Scavengers
May eliminate free radicals and among other effects, they may protect pancreatic islets against damage by cytokines and may prevent myocardial and pulmonary reperfusion injury.
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they may have analgesic, antipyretic, and platelet-inhibitory actions. They may act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
Cholagogues and Choleretics
Gastrointestinal agents that may stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).
May assist in the management of used in the treatment vascular hypertension.
Substances that may prevent infectious agents or organisms from spreading or may kill infectious agents in order to prevent the spread of infection.
Substances may that destroy fungi by suppressing their ability to grow or reproduce. That is a potential defence against fungi present in human or animal tissues.
Agents that may soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.
Agents that may reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved.
Anti-neoplastic Agents, Phytogenic
Agents obtained from higher plants that may have demonstrable cytostatic or antineoplastic activity.
Compounds or agents that may combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Platelet Aggregation Inhibitors
Drugs or agents which may antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Agents that may reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved.
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES)